Foster City, CA, United States
Gilead Sciences, Inc. recalls
2 recalls recorded since 2018, most recently on 19 September 2024. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls2
Ongoing (FDA)0
Terminated or completed2
Class I (FDA)2
Terminated Class I Drugs
- Recall started
- 19 September 2024
- Terminated
- 29 July 2025
- Reason
- Presence of Particulate Matter: Presence of glass particle.
- Distribution
- Nationwide in the U.S.A.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0005-2025
- Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Terminated Class I Drugs
- Recall started
- 3 December 2021
- Terminated
- 25 July 2022
- Reason
- Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
- Distribution
- Nationwide in the USA
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0299-2022
- Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.